All news

Wall Street Zen trims CVS Health rating to buy

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Wall Street Zen lowered its rating on CVS Health (NYSE:CVS) from "strong buy" to "buy," while the broader analyst consensus remains a "Moderate Buy" with an average price target of

Read original source

CVS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.